Literature DB >> 30664877

Long-term Safety and Efficacy of Local Microinjection Combining Autologous Microfat and Adipose-Derived Stromal Vascular Fraction for the Treatment of Refractory Perianal Fistula in Crohn's Disease.

Mélanie Serrero1, Fanny Grimaud2, Cécile Philandrianos3, Carine Visée4, Florence Sabatier5, Jean-Charles Grimaud6.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30664877     DOI： 10.1053/j.gastro.2019.01.032

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

Review 1.  Stem cell transplantation for induction of remission in medically refractory Crohn's disease.

Authors:  Sarah El-Nakeep; Ahmed Shawky; Sara F Abbas; Osama Abdel Latif
Journal:  Cochrane Database Syst Rev       Date:  2022-05-13

2.  Mesenchymal Stem Cells Alleviate Inflammatory Bowel Disease Via Tr1 Cells.

Authors:  Lingli Qi; Jing Wu; Shan Zhu; Xue Wang; Xinping Lv; Chunyan Liu; Yong-Jun Liu; Jingtao Chen
Journal:  Stem Cell Rev Rep       Date:  2022-03-10       Impact factor: 6.692

Review 3.  Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease.

Authors:  M C Barnhoorn; S K Hakuno; R S Bruckner; G Rogler; L J A C Hawinkels; M Scharl
Journal:  J Crohns Colitis       Date:  2020-07-30       Impact factor: 9.071

Review 4.  Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.

Authors:  Jeffrey Zheng-Hsien Ko; Sheeva Johnson; Maneesh Dave
Journal:  Biomolecules       Date:  2021-01-11

Review 5.  Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon's Point of View.

Authors:  Jong Lyul Lee; Yong Sik Yoon; Chang Sik Yu
Journal:  Ann Coloproctol       Date:  2021-02-28

Review 6.  Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases.

Authors:  Fangfang Huang; Erick Thokerunga; Fajian He; Xinyu Zhu; Zi Wang; Jiancheng Tu
Journal:  Stem Cell Res Ther       Date:  2022-01-08       Impact factor: 6.832

7.  Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn's disease.

Authors:  Lucas Guillo; Fanny Grimaud; Fanny Houser; Caroline Prost; Elisabeth Jouve; Cécile Philandrianos; Maxime Abellan; Julie Veran; Carine Visee; Laura Beyer-Berjot; Ariadne Desjeux; Françoise Dignat-George; Marc Leone; Jean-Charles Grimaud; Florence Sabatier; Mélanie Serrero; Jérémy Magalon
Journal:  Stem Cell Res Ther       Date:  2022-02-09       Impact factor: 6.832

Review 8.  Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy.

Authors:  Yifei Wang; Bin Huang; Tao Jin; Dickson Kofi Wiredu Ocansey; Jiajia Jiang; Fei Mao
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561

9.  Effect of uncultured adipose-derived stromal vascular fraction on preventing urethral stricture formation in rats.

Authors:  Liuhua Zhou; Tianli Yang; Feng Zhao; Kaiwei Song; Luwei Xu; Zhongle Xu; Changcheng Zhou; Zhiqiang Qin; Zheng Xu; Ran Wu; Hua Xu; Ruipeng Jia
Journal:  Sci Rep       Date:  2022-03-04       Impact factor: 4.379

Review 10.  Managing complex perianal disease after anti-TNF failure: Where to go next?

Authors:  Clare Yzet; Franck Brazier; Charles Sabbagh; Mathurin Fumery
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-01-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.